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Purpose: This study is devoted to optimizing and characterizing the response of a multipoint plastic scintillator
detector (mPSD) for application to in vivo dosimetry in HDR brachytherapy.
Methods: An exhaustive analysis was carried out in order to obtain an optimized mPSD design that maximizes
the scintillation light collection produced by the interaction of ionizing photons. More than 20 prototypes of mPSD
were built and tested in order to determine the appropriate order of scintillators relative to the photodetector (distal,
center or proximal), as well as their length as a function of the scintillation light emitted. The available detecting
elements are the BCF-60, BCF-12 and BCF-10 scintillators (Saint Gobain Crystals, Hiram, OH, USA), separated
from each other by segments of Eska GH-4001 clear optical fibers (Mitsubishi Rayon Co., Ltd., Tokyo, Japan). The
contribution of each scintillator to the total spectrum was determined by irradiations in the low energy range (<
120 keV). For the best mPSD design, a numerical optimization was done in order to select the optical components
(dichroic mirrors, filters and photomultipliers tubes (PMTs)) that best match the light emission profile. Calculations
were performed taking into account the measured scintillation spectrum and light yield, the manufacturer-reported
transmission and attenuation of the optical components, and the experimentally characterized PMT noise. The
optimized dosimetric system was used for HDR brachytherapy measurements. The system was independently
controlled from the 192Ir source via LabVIEW and read simultaneously using an NI-DAQ board. Dose measurements
as a function of distance from the source were carried out according to TG-43U1 recommendations. The system
performance was quantified in terms of signal to noise ratio (SNR) and signal to background ratio (SBR).
Results: For best overall light-yield emission, it was determined that BCF-60 should be placed at the distal
position, BCF-12 in the center and BCF-10 at the proximal position with respect to the photodetector. This
configuration allowed for optimized light transmission through the collecting fiber and avoided inter-scintillator
excitation and self-absorption effects. The optimal scintillator length found was of 3 mm, 6 mm, and 7 mm for
BCF-10, BCF- 12 and BCF-60, respectively. The optimized luminescence system allowed for signal deconvolution
using a multispectral approach, extracting the dose to each element while taking into account the Cerenkov stem
effect. Differences between the mPSD measurements and TG-43U1 remain below 5% in the range of 0.5 cm to 6.5
cm from the source. The dosimetric system can properly differentiate the scintillation signal from the background
for a wide range of dose rate conditions: the SNR was found to be above 5 for dose rates above 22 mGy/s while the
minimum SBR measured was 1.8 at 6 mGy/s.
Conclusion: Based on the spectral response at different conditions, an mPSD was constructed and optimized for
HDR brachytherapy dosimetry. It is sensitive enough to allow multiple simultaneous measurements over a clinically
useful distance range, up to 6.5 cm from the source. This study constitutes a baseline for future applications enabling
real time dose measurements and source position reporting over a wide range of dose rate conditions.
Keywords: in vivo dosimetry, plastic scintillator, multi points plastic scintillation detector, HDR brachytherapy
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I. INTRODUCTION
In brachytherapy, radioactive sources are placed at a short distance from the target. The
high dose gradients near brachytherapy sources (10% or more per millimeter for the first few
centimeters from the source) provide a level of protection to healthy tissues surrounding the
target. Despite the short distances involved in this modality, brachytherapy is not free from
errors, which can be caused by humans (e.g., incorrect medical indication, source strength,
patient identification, catheter, or applicator) or by failures in the treatment system (e.g.,
mechanical events)1. Even small errors in the source positioning can result in harmful con-
sequences for patients. Systematic implementation of precise quality control and quality
assurance protocols help to improve treatment quality, and routine use of real-time verifi-
cation systems and in vivo dosimetry are even more helpful in determining whether there
are deviations from the prescribed dose during treatment delivery. Performing these tasks
requires a precise and accurate detector whose presence does not perturb the particle fluence
and the physics interactions. Tanderup et al.2 reviewed different detectors for potential use
for in vivo brachytherapy dosimetry. The selection of the appropriate dosimetric system is
a compromise between different requirements and constraints of the detector as well as the
application sought.
Plastic scintillator detectors (PSDs) show promise for obtaining accurate real-time ra-
diotherapy dose measurements. Previous studies have demonstrated that PSDs can accu-
rately measure dose in external beam radiotherapy and that they have high spatial res-
olution, linearity with dose, energy independence in the megavolt energy range, and wa-
ter equivalence3–12. In addition, some authors have found PSDs to be feasible for use in
brachytherapy applications13–17. Despite the aforementioned advantages, PSD response is
affected by the stem effect and temperature dependence. Temperature dependence was long
considered to be negligible, but recent studies showed that, depending on the type of scin-
tillator, changes on the order of 0.6% per degree Celsius should be expected9,18. Moreover,
a non-negligible fraction of the light collected by PSDs consists of the stem effect which can
be caused by two phenomena. The first phenomenon is direct excitation of the polymer
chain, or fluorescence, from the plastic optical fiber guides, and the second is Cerenkov light
production. Therriault-Proulx et al.29 found that fluorescence yield is order of magnitude
less intense than Cerenkov light. The intensity of Cerenkov light emitted in the optical
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fiber guide is up to 2 orders of magnitude lower per millimeter than the intensity of the
scintillation light produced by the scintillator. However, the optical fiber guides within the
radiation field are usually much longer than the scintillation probes, several centimeters
versus a few millimeters at most for the scintillators30. Whether Cerenkov light requires
removal in brachytherapy applications depends on the radioactive source used and the mea-
surement geometry. In HDR brachytherapy with an 192Ir source, Cerenkov radiation can
cause large errors in dose reporting if it is not taken into account14,15. The production and
removal of Cerenkov light in PSDs are widely discussed topics6,11,12,19–22,30. In this study,
the stem effect is accounted for.
Most studies that have characterized PSDs have been conducted using an optical fiber
connected to a single point of measurement as the sensitive volume. Multiple scintillation
sensors attached to a single optical chain have been used, but their application is limited
to measurements made within 3 cm of an HDR brachytherapy source22–24. New multipoint
PSDs (mPSDs) could assess the dose at multiple points simultaneously, thereby improv-
ing treatment quality and accuracy. The multi-hyperspectral filtering method proposed by
Archambault et al.22 led to the conception of an mPSD in which each scintillator has an
independent signal. Such an arrangement would allow simultaneous determination of the
absorbed dose at different locations in a volume23–25.
The purpose of this study was to evaluate the performance of an mPSD in terms of
sensitivity and accuracy, resulting in a thorough optimization of the optical chain, with
applications to in vivo HDR brachytherapy in mind. To achieve this goal, three steps
were followed. First, an experimental study was carried out to look for an optimal mPSD
configuration. As the second step, we performed numerical optimizations to determine the
proper configuration of the scintillation light detection system. In a third, and final stage,
we evaluated the performance of the entire system in HDR brachytherapy.
II. MATERIALS AND METHODS
II.A. Optical chain
The optical chain in the proposed system has components that (1) generate scintillation
light in the mPSD, (2) detect the scintillation light, and (3) analyze the signal.
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Fig. 1 Design schematic of an mPSD. sc1 and sc2 indicate scintillators 1 and 2, respectively; l1
and l2 denote the scintillators lengths. s is the separation between the scintillators, 1 cm of clear
optical fiber. Figure not to scale. SMA, subminiature version A.
The scintillating fibers used in this study were the plastic scintillators BCF-10, BCF-12,
and BCF-60 from Saint Gobain Crystals (Hiram, OH, USA). Figure 1 shows the design
schematic of a typical mPSD. The scintillators were separated from each other by 1 cm of
clear optical fiber (Eska GH-4001, Mitsubishi Rayon Co., Ltd., Tokyo, Japan). The same
type of fiber was also used to conduct the scintillating light to the photodetector surface.
(Here, “clear” refers to a fiber in which no scintillation light is produced.) The aim of this
study is to optimize a 3-point mPSD configuration. A single investigation with a 2-point
mPSD was carried out, which is described in the following sections. All optical interfaces
(scintillators and clear optical fibers) were polished using a SpecPro automated optical fiber
polisher (Krell Technologies, Neptune City, NJ, USA) with successive grain sizes of 30 µm,
9 µm, 3 µm, and 0.3 µm. The detectors were constructed using a previously described
coupling technique26.To ensure the reproducibility of the polishing and coupling techniques,
we verified that the light collection across multiple detector samples does not vary more than
5 %. Each 1-mm-diameter detector prototype was made light-tight using a black polyether
block amide jacket from Vention Medical (Salem, NH, USA). The scintillating tip was sealed
with a mixture of epoxy and black acrylic paint.
The scintillation light signal was guided to the photodetector surface by a clear optical
fiber, which was attached to the photodetector with a subminiature version A connector
(11040A, Thorslab, Newton, NJ, USA). Two types of photodetector were used: (1) an
Ocean Optics QE65Pro spectrometer (Dunedin, FL, USA) and (2) a set of photomultiplier
tubes (PMTs) coupled to dichroic mirrors and filters from Hamamatsu (Bridgewater, NJ,
USA)27. When the PMTs were used as the photodetector, the signal was read by a data
acquisition board (NI USB-6289 M Series Multifunction I/O Device, National Instruments,
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Austin, TX, USA), and LabVIEW software version 15.0f2 (National Instruments) was used
during the signal analysis stage28.
II.B. Experimental determination of the optimal mPSD configuration
The purpose of this step was to identify the best configuration of scintillators in an mPSD.
Interchangeable radiosensitive tips containing the scintillators were coupled to a clear optical
fiber, which conveyed the light signal to the photodetector. We built and tested more than
20 mPSD prototypes using various combinations of scintillator positions and lengths to
determine (1) the optimal position for each scintillator within the fiber and (2) the optimal
length of each scintillator.
To evaluate the effect of scintillator position on the recorded signal, (A) the lengths of
the scintillators inside the radiosensitive tips were kept identical (3 mm of BCF-10, 6 mm
of BCF-12, 7 mm of BCF-60), and (B) the positions of the scintillators inside the fiber
were altered. Each scintillator was placed in a distal, central, or proximal position relative
to the photodetector surface. To determine the optimal scintillator length in terms of the
scintillation light produced and spatial resolution, each scintillator was varied in length from
3 mm to 14 mm. The hyperspectral approach22 dictated a balanced signal contribution from
each scintillator to the overall light collection, while the spatial resolution of the dose required
detection elements that were as small as possible.
For each possible combination of scintillator number, position, and length, the total
emission spectrum was obtained from simultaneous irradiation of all the scintillators in the
fiber. Then, in order to obtain their individual contributions to the total emission spectrum,
each scintillator was individually irradiated. Lead blocks were used to shield the neighboring
scintillators from the incoming radiation.
The spectral distributions were obtained with the spectrometer cooled to -20 ◦C and the
integration time set to 40 s. Background signals acquired prior to exposures were subtracted
from the scintillation light signals.
The analysis in this section was performed under a fixed irradiation condition with an
X-ray therapy system. A tube voltage of 120 kV (maximum photon energy of 120 keV) was
selected to avoid Cerenkov light production. Several measurements were carried out in the
low-energy range using an Xstrahl 200 (Xstrahl Ltd., Camberley, UK). Continuous beam
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Table I Main irradiation parameters when using a Xstrahl 200 x-ray therapy system.
Energy HV L1 Added filtration Field size
(kV) (mm) (mm) (cm)
120 5.0 Al 0.5 Al+0.10 Cu 10∗
HVL = Half-Value Layer
∗ diameter to circular shape
irradiations with a tube current of 10 mA were performed according to the specifications
shown in Table I.
II.C. Determination of the optimal scintillation light detection system.
In the second step, we sought the appropriate optical components for the light detec-
tion system used during measurements. Having a complete spectral characterization led us
to perform a numerical analysis to determine the optical chain that would allow optimal
scintillation light collection.
In our experimental set-up, scintillation light was read by an assembly of PMTs, which
were coupled to a set of dichroic mirrors and filters that deconvolved the collected light into
spectral bands. PMTs were chosen as the photodetectors because they have a high signal-
to-noise ratio (SNR) and readout speed that overcomes many of the sensitivity issues of
charge-coupled device-based systems. Generally, PMTs more accurately measure low light
signals and have a faster response, making them more suitable for the demands of in vivo
dosimetry applications5,16,32. Henceforth, an assembly composed of a dichroic mirror, filter,
and PMT will be referred to as a “channel”. From an optimization perspective, the signal
produced in each channel was calculated, taking into account the measured scintillation
spectrum and light yield, the manufacturer-reported transmission and attenuation of the
optical components, and the experimentally characterized PMT noise. The experimental
spectral characterization obtained for the mPSD constituted the main input. That spectral
information was then used to construct the optical system and simulate its response when
interacting with a radiation beam. No particle transport through Monte Carlo simulations
was performed. A large set of possible component combinations (brute force) was explored
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to find the configuration that provided the best SNR. For the calculations, we used the
characteristics of filters and dichroic mirrors from Hamamatsu series A10033 and A10034,
respectively. For the PMTs, the models used corresponded to Hamamatsu series H10722.
The numerical optimization took into account the fact that the number of channels depended
on the number of scintillator points N composing the mPSD and equaled N + 1. This
procedure allowed us to optimize light transmission and to minimize the contribution of
elements generating spurious light (as will be shown in Figure 7).
II.D. Performance of the mPSD system in HDR brachytherapy
With the optimized system, we next evaluated the performance of a 3-point mPSD in
HDR brachytherapy. A Flexitron HDR afterloader (Elekta, Stockholm, Sweden) was used
with an 192Ir source. The cylindrical 192Ir source pellet was 0.6 mm in diameter and 3.5
mm in length and was housed inside a stainless steel capsule 0.86 mm in diameter and 4.6
mm in length. The source air kerma strength was 32226 U . The HDR brachytherapy unit
was remotely controlled and able to move the source to the desired position in a water tank
by means of a 30 cm needle set from Best Medical International (Springfield, VA, USA).
The mPSD dimensions allowed it to be inserted into an additional catheter for use during
real-time dose verification.
To be consistent with the TG-43U1 formalism31, measurements were performed with the
source and detector isotropically covered by at least 20 cm of water. To ensure the accuracy
and reproducibility of the source-to-detector distance, all the catheters were inserted in a
custom-made poly(methyl methacrylate) phantom (Figure 2a), which was in turn placed
inside a 40 × 40 × 40-cm3 water tank. As shown in Figure 2,the phantom was composed of
2 catheter insertion templates of 12 × 12 cm2, separated by 20 cm. This phantom allowed
for source-to-detector parallel displacement. Figure 2b shows the experimental set-up used
during measurements. 10 catheters were inserted in the template phantom at distances
ranging from 0.5 cm to 7.0 cm away from the mPSD catheter. Three dwell positions per
catheter were planned. Following the axis convention shown in figure 2a, the source z
locations were chosen relative to the effective center of each scintillator volume.
The dosimetric system was initially calibrated under the same conditions used to perform
the measurements, following the TG-43U131 and hyperspectral22 formalisms. The lumines-
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Fig. 2 (a) Schematic of the poly(methyl methacrylate) (PMMA) phantom constructed for HDR
brachytherapy measurements with an mPSD. The catheter positioning allowed source displacement
parallel to the mPSD. (b) Experimental set-up for HDR brachytherapy measurements. (1) PMMA
phantom, (2) mPSD, (3) 192Ir source, (4) 30-cm catheters, (5) Flexitron HDR afterloader unit,
(6) 40 × 40 × 40-cm3 water tank, (7) solid-water slabs.
cence dosimetry system was controlled using LabVIEW software. A gain input voltage of 1
V was assigned to each PMT, producing a channel output of 2×106. The linear relationship
between the input voltage and the gain was assessed for voltage between 0.5 V and 1.1 V.
For each measurement channel, 70000 samples per second were acquired. Dose values were
recorded in real time by the mPSD. All measurements were repeated at least 5 times, and
the measurement set-up was completely unmounted between each measurement. Statistical
variations in the readings were determined by setting a source dwell time of 60 s per dwell
position.
The sensitivity of the dosimetry system was evaluated using the SNR and the signal-to-
background ratio (SBR) associated with each scintillator during HDR brachytherapy mea-
surements. Figure 3 is a representation of a typical signal pulse, showing the magnitudes that
were used in SNR and SBR determination: µs, the mean signal; µb, the mean background
signal; σs the signal standard deviation; and σb the background standard deviation.
SNR =
µs
σs
(1)
9
Fig. 3 Typical signal pulse used for signal-to-noise ratio and signal-to-background ratio calcu-
lations. The indicated values are: µs, mean signal value; µb, mean background value; σs, signal
standard deviation; σb, background standard deviation and the difference between µs and µb.
SBR =
µs
µb
(2)
The SNR is a commonly used metric for characterizing the global performance of optoelec-
tronic systems. In the case of PSD performance assessment, the noise term includes Cerenkov
radiation. A few SNR studies using PMTs as the photodetector have been performed32–34.
The scintillator SNR as function of dose rate was obtained using equation 1, where the
numerator represents the mean signal for a determined irradiation in a fixed time, and the
denominator is the standard deviation of the collected signal. SBR was determined accord-
ing to equation 2 and is the ratio of the mean signal value and the mean background value
for a fixed irradiation time.
II.E. Cerenkov radiation removal
In our study, multiple probes were read by a single clear collecting optical fiber; thus, we
used the hyperspectral filtering technique proposed by Archambault et al.22 as the stem effect
removal method during HDR brachytherapy measurements. Equations 3, 4 and 5 represent
the removal method for an mPSD configuration. Dose calculation in mPSDs is based on the
assumption that the recorded signal results from the linear superposition of spectra; no self-
absorption interactions among the scintillators composing the mPSD are considered22. The
idea behind this formalism is that once the light emission of each component at different
wavebands is known, the total signal recorded can be decoupled, and the signal fraction
10
contributed by each scintillator can be determined.
m = Rx (3)

dp1,1 dp1,2 dp1,3 dp1,4
dp2,1 dp2,2 dp2,3 dp2,4
dp3,1 dp3,2 dp3,3 dp3,4
 =

Cp1,L1 Cp1,L2 Cp1,L3 Cp1,L4
Cp2,L1 Cp2,L2 Cp2,L3 Cp2,L4
Cp3,L1 Cp3,L2 Cp3,L3 Cp3,L4
×

mL1,1 mL1,2 mL1,3 mL1,4
mL2,1 mL2,2 mL2,3 mL2,4
mL3,1 mL3,2 mL3,3 mL3,4
mL4,1 mL4,2 mL4,3 mL4,4
(4)
d′ = C ×m′ (5)
A raw measurement m with the mPSD system is a function of a given photon flux x (the
number of photons emitted for a given emission source, either scintillating elements or any
other source of light) and the system response matrix R. In equation 3, m is a vector of L
elements; R is L × N dimensions, and x is a vector of N elements. L represents different
wavelength filters or channels. The number of measurement channels L should be equal to
N +1. The additional channel is included to take into account the stem effect, which should
be removed from the measured signal14.
Equation 4 is the mathematical equation for determination of the calibration factor. The
dose di;k received by the scintillator during irradiation is directly proportional to the number
of scintillation photons in the absence of losses (quenching); for this reason, di,k = aixi,k,
ai being a proportionality constant and xi,k the photon fluence in the scintillating material
i during the measurement at position k. However, knowing the dose at a specific point
requires a previous calibration to determine the calibration factor C for each scintillation
point as well as each measurement channel. For such a calibration the dose (e.g., dp1,p2,p3,p4
) should be known at each point p. We calculated these dose values by using the TG-43U1
formalism31. To account for the finite size of each scintillator, TG-43U1 dose values were
integrated over each scintillator’s sensitive volume.
Once the calibration factor C is known, the dose d′ at each point can be determined
using equation 5, where m′ represents the raw data acquired during measurements. The
apostrophe in equation 5 is used to highlight that this is a new set of measurements, the
goal of which is to determine the absorbed dose, not the calibration factor, which is already
known at this stage.
11
Fig. 4 Individual scintillator spectra normalized to a 1-mm-long scintillator.
III. RESULTS AND DISCUSSION
III.A. mPSD optimal configuration
III.A.1. Scintillator position within the fiber
A single investigation was performed with a 2-point mPSD configuration to determine
the optimal order of scintillators in the mPSD. Each scintillator spectrum was measured
independently. Figure 4 shows the individual spectra with intensities normalized to a 1-mm
scintillator length. As shown in the figure, the scintillation intensity was strongest in the
BCF-10 scintillator, whereas the BCF-60 scintillator had the weakest scintillation intensity.
In all the tested combinations, the scintillator’s individual spectra evidenced no self-
absorption or cross-excitation effects. The main differences observed related to the position
occupied by each scintillator inside the fiber. Table II shows the measured signal proportion
for different 2-point mPSD configurations. For each configuration, the proportion of the
total signal coming from each independent scintillator was calculated by determining the
area under the curve. The signal proportion was more balanced when a BCF-60 scintillator
was placed in the distal position and coupled to a BCF-10 scintillator. At 530 nm, the BCF-
60 signal represented 37% of the total signal when coupled to a BCF-10 scintillator but only
9% when coupled to a BCF-12 scintillator. Therefore, this combination of scintillators and
positions is recommended for a 2-point mPSD.
The signal analysis demonstrated that the shorter wavelength scintillator should always
12
Table II Scintillator signal proportion (in %) for each combination of scintillators and positions
inside the optical fiber.
Proximal
BCF-10 BCF-12 BCF-60
D
is
ta
l BCF-10 - 8.6/91.4 17.6/82.4
BCF-12 18.8/81.2 - 7.2/93.8
BCF-60 37.4/62.6 8.8/91.2 -
be placed closer to the photodetector and the longer wavelength scintillator in the distal
position. Because of the Stokes shift, the absorption spectrum always has a lower wavelength
range than the emission spectrum. If the aforementioned configuration is not used, inter-
scintillator excitation and self-absorption effects can take place, and as a consequence, the
light transmission through the collecting fiber is not optimal. To exemplify this effect, 3-
point mPSDs with 2 different configurations of scintillator positions inside the fiber were
constructed. Their spectral distributions are shown in Figure 5. Figure 5a shows the spectra
with the BCF-10 placed at the distal position, the BCF-60 in the center, and the BCF-12
in the proximal position. Almost all of the light produced by the BCF-10 scintillator was
absorbed by the neighboring scintillators, whose photon intensities were higher than they
were in the optimal configuration (Figure 5b). Hence, in the subsequent experiments, we
used mPSDs in which the scintillators were placed inside the optical fiber in decreasing order
of wavelength from distal to proximal positions.
In the case of a 3-point mPSD composed of 3 mm of BCF-60 at the distal position, BCF-
12 in the center, and BCF-10 at the proximal position (mPSD prototype P1 in Figure 6),
we observed no self-absorption or cross-excitation effects, but the scintillator’s independent
signals were not balanced at all. In such a case, the scintillation process is more efficient in
BCF-10 than in the other scintillators, accounting for almost 71% of the total signal. The
intensities of BCF-12 and BCF-60 were closer to one another, with 20% and 9% of the total
signal, respectively.
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Fig. 5 (a) Stokes shift effect. (b) Spectral distributions obtained with all scintillators in the
optimal positions.
Fig. 6 Fraction of the total scintillation light produced by each scintillator as a function of its
length. The shaded region indicates the combination of sensor lengths that result in balanced
signals.
III.A.2. Optimal scintillator length
The intensity of the measured scintillation light depends on the scintillator size, the cou-
pling method, the fiber core size, and the fiber numerical aperture. To determine the optimal
length of each scintillator, 9 different 3-point mPSD prototypes were constructed. Figure
14
Fig. 7 Schematic of the light collection system obtained from calculations. All the components
used were from Hamamatsu. D indicates dichroic mirrors from series A10034, F indicates filters
from series A10033, and P210 and P020 refer to PMTs H10722 210 and 020, respectively. CH
indicates the channel number. FN refers to a filter that transmits 100% of the incoming light to
the photodetector in the wavelength range of 300 nm to 500 nm
.
6 shows the contributions of individual scintillator signals for each of the 3-point mPSDs
and specifies the length of each scintillator in millimeters. As indicated by the shadowed
region in Figure 6, detector configurations P6 to P9 provided the required balanced signals
for optimal hyperspectral deconvolution. P9 was selected as the optimal detector because
it also minimized variations in sensor length. In the P9 mPSD, the BCF-10 scintillator was
3 mm long, the BCF-12 scintillator was 6 mm long, and the BCF-60 scintillator was 7 mm
long.
III.B. Optimized scintillation light detection system
Following the determination of the optimal length, the numerical optimization allowed
us to determine the best combination of components to be used for the measurements of the
light collection system. Figure 7 shows a schematic of the appropriate arrangement of the
components of the light collection system obtained from these calculations.
This assembly filtered the total emission spectrum from the mPSD to produce a filtered
spectrum entering each PMT. The PMT’s voltage output is then used to calculate the
absorbed dose in the absence of Cerenkov radiation. Figure 8 shows each channel’s filtered
spectrum and the total emission spectrum of the scintillation light generated by the P9
15
Fig. 8 Emission and filtered spectra produced by the P9 mPSD prototype used for absorbed dose
determination. The filtered spectra for each channel were obtained by applying optical filtration
to the light entering each PMT.The intensities in the emission and filtered spectra are normalized
to their maximum intensity.
mPSD.
The study done by Therriault-Proulx et al.25 in HDR brachytherapy uses the same scin-
tillating elements described in this work (BCF-10, BCF-12, and BCF-60; Saint-Gobain
Crystals, Hiram, OH), but with different positions inside the optical assembly. In that work
it was suggested to use the BCF-10 in the central position while BCF -12 at the proximal
position with respect to the photodetector surface. Based on the signal analysis performed
in this study, we propose an optimized mPSD design that maximizes the scintillation light
collection, resulting in the configuration shown in Figure 7, which inverts the BCF-10 and
BCF-12 positions.
III.C. Performance of the mPSD system in HDR brachytherapy
III.C.1. Absorbed dose as function of distance
Dose distributions in terms of distance to an HDR brachytherapy source were obtained,
with the P9 mPSD calibrated at 1.5 cm from the 192Ir source. This calibration distance
represented a compromise between measurement uncertainties and positioning uncertainties.
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Fig. 9 Scintillator dose rates as a function of distance to the HDR brachytherapy source. The
distances to the source are relative to each scintillator effective center.
Andersen et al.35 demonstrated that positioning uncertainty dominates in measurements
close to the source, whereas measurement uncertainty dominates at long distances. In order
to ensure that we had enough data in the response recording, a source dwell time of 60 s
was used at each dwell position.
Figure 9 shows dose rate readings for each scintillator, and Table III details the standard
deviations for each distance to the brachytherapy source. For all 3 scintillators, the standard
deviations were generally no greater than 5% of the mean dose reading, although this value,
as expected, increased with distance from the source. At a distance of 6.5 cm, the standard
deviation exceeded 10% for all scintillators. At that distance, the source radiation does not
produce enough scintillation in the mPSD, so the recorded signal can be considered to be
background. Nonetheless, the absolute standard deviation was small relative to the mean
dose.
TG-43U1 dose values were used as a reference; the last column in Table III presents the
differences between the measured dose and the TG-43U1 dose values at each distance to the
brachytherapy source. In general, the measured mPSD dose and the TG-43U1 dose agreed
well at short distances to the source, but the difference increased as the source moved away
from the mPSD.
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Table III Standard deviation (SD) of 3-point mPSD measurements and deviation of the mean
measured dose from the values predicted by TG-43U1. The distances to the source are relative to
each scintillator effective center.
Distance Dose per Deviation
to source 1s reading SD from TG-43U1
(cm) (mGy) (%) (mGy) (%) (mGy)
B
C
F
-1
0
0.5 1117.9 0.7 7.7 3.0 33.2
0.7 594.4 0.7 4.2 1.1 6.5
1.0 332.0 1.2 4.1 1.1 3.6
1.1 261.6 1.6 4.2 3.7 9.7
1.5 138.7 2.8 3.9 3.8 5.3
2.0 80.9 4.2 3.4 5.5 4.5
2.5 51.3 4.5 2.3 7.5 3.9
3.2 31.0 4.1 1.3 7.3 2.3
6.5 6.0 12.8 0.8 21.3 1.3
B
C
F
-1
2
0.5 2146.6 0.5 10.3 1.1 23.2
0.7 1082.6 0.7 7.2 0.8 9.1
1.0 633.6 0.8 5.3 2.5 15.6
1.1 500.9 0.8 3.9 2.2 11.1
1.5 255.4 2.0 5.2 2.0 5.1
2.0 144.8 4.2 6.1 2.2 3.2
2.5 94.6 3.1 2.9 2.0 1.9
3.2 56.6 3.2 1.8 2.3 1.3
6.5 13.3 11.2 1.5 12.4 1.6
B
C
F
-6
0
0.5 2881.6 0.4 11.3 2.3 66.9
0.7 1293.6 0.7 8.5 0.6 7.2
1.0 778.5 1.2 9.4 3.4 26.7
1.1 614.3 1.2 7.1 4.3 26.3
1.5 302.6 1.7 5.0 0.8 2.5
2.0 175.2 6.5 11.4 1.0 1.8
2.5 119.2 5.0 5.9 2.4 2.9
3.2 68.1 6.8 4.6 1.7 1.2
6.5 21.9 20.9 4.6 13.7 3.0
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Fig. 10 Signal-to-noise ratio (SNR) and (b) signal-to-background ratio (SBR) as a function of
dose rate for BCF-10, BCF-12, and BCF-60 scintillators in the P9 mPSD prototype. Shaded areas
at the bottom of the graphs indicate the cutoff values for each parameter.
III.C.2. Evaluation of scintillation signal and system sensitivity
Figure 10a shows the SNR in terms of dose rate for each scintillator in detector P9.
According to the Rose criteria, proper recognition (detection) of an object strongly depends
on SNR, only becoming possible when SNR exceeds 5; detection performance degrades as
SNR approaches zero36. Thus, an SNR of 5 was the minimum sensitivity considered in
this study. The BCF-10 and BCF-12 scintillators produced an SNR greater than 5 at all
distances to the source. At dose rates below 22 mGy/s, the SNR produced by the BCF-
60 scintillator fell below 5. These data suggest that, with regard to SNR, the dosimetric
system characterized in this study is sensitive enough to measure dose rates above 22 mGy/s
at distances to the source below 6.4 cm.
SNR analysis of PSD responses for various photodetectors was conducted by Boivin et
al.32 in the energy range of clinical interest. SNR values in a range of 100 to 1000 for dose
rates between 0.1 mGy/s and 30 mGy/s were reported, being around 2 orders of magnitude
greater than the results obtained in the low dose rate range of this study. The differences
are easily explained by the differences in design. First, the study done by Boivin et al.32
was conducted with a single point configuration detector that only had a single coupling
interface, while the one reported in this study has 5 coupling interfaces intrinsicly decreasing
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the overall light collection in mPSD. Secondly, the scintillator size used in the study done
by Boivin et al.32 was 10 mm vs. a maximum size of 7 mm in the mPSD. Thirdly and most
important, the system used here is subject to optical filtration of the light produced; Boivin
et al.32 used a system with no optical filtration, recording the signal of a PSD directly on a
PMT module.
To evaluate how well the dosimetric system differentiated a signal pulse from the back-
ground signal, SBR values were calculated at each dose rate. Furthermore, several signal
acquisitions were performed without irradiation resulting in a background signal value of µb
± 0.16 %. To properly differentiate signal from background, a minimum SBR of 2 is required.
Figure 10b shows the SBR results obtained for each scintillator in the mPSD. The SBR for
the BCF-10 scintillator fell below the SBR cutoff value for dose rates of around 6 mGy/s at
6.5 cm relative to the source, with an SBR of 1.8. The SBR is directly proportional to the
photon fluence from scintillation, which is in turn proportional to the scintillator volume.
According to the previously determined optimal mPSD design, the length of the BCF-10
scintillator was only 3 mm. The dose rate range could be extended by increasing the length
of the scintillator, but at the cost of spatial or temporal resolution. As the background
signal was almost constant in the explored dose rate range, all the scintillators evidenced
almost perfectly linear behavior.
The mPSD system studied by Therriault-Proulx et al.25 is limited to HDR brachytherapy
measurements within 3 cm from the source. The system proposed here is able to accurately
perform dose measurements beyond 3 cm with a high collection efficiency.
IV. CONCLUSIONS
In this study, we optimized an mPSD system that can be used clinically in HDR
brachytherapy. We found that the scintillation light emission per millimeter of scintil-
lator was more efficient in BCF-10 than in BCF-12 or BCF-60 scintillators. Furthermore,
we experimentally determined the appropriate position of each scintillator inside the fiber:
the scintillating element with the shorter wavelength should be placed closer to the photode-
tector, whereas the scintillator with the longer wavelength should be placed distally. In a
2-point mPSD, the most balanced signal was obtained with BCF-10 placed proximally and
BCF-60 placed distally. We also evaluated a 3-point mPSD consisting of BCF-10, BCF-12,
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and BCF-60 scintillators. The best prototype used 3 mm of BCF-10, 6 mm of BCF-12, and
7 mm of BCF-60. Those dimensions were determined not only on the basis of light emis-
sion balance, but also with the aim of improving the detector’s spatial resolution. Finally,
an optimal light collection system was evaluated in HDR brachytherapy simulations. The
evaluated mPSD produced minimal deviations in dose rate readings, and analysis of SNR
and SBR showed that the detector provided accurate real-time dose measurements.
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